METHODS	This multicenter open randomized crossover trial in 59 type 1 diabetic subjects comprised a 2-week run-in period on a basal-bolus regimen with NPH insulin once daily , followed by two 6-week periods of optimized basal-bolus therapy with either once-daily insulin detemir or NPH insulin .\